The study also revealed a significant trend in terms of older age distribution (median 59.3 years) and utilization of matched unrelated donors (45.2%) in more recent times [ 51 ].
← all excerpts
Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm.
1
—
—